The Chinese Journal of Cancer is a peer-reviewed, open-access journal dedicated to advancing cancer research and improving patient outcomes. With a focus on studies originating from or relevant to the Chinese population, the journal provides a crucial platform for disseminating findings on cancer epidemiology, etiology, prevention, diagnosis, and treatment. The journal aims to promote collaboration and knowledge exchange among researchers and clinicians in China and worldwide, fostering innovation and progress in cancer care.
Areas of focus include basic cancer biology, translational research, clinical trials, and novel therapeutic approaches. The journal actively seeks submissions that address the unique challenges of cancer in China, such as disparities in access to care, the impact of environmental factors, and the genetic characteristics of specific cancers. Key areas covered include gastric cancer, liver cancer, lung cancer, and esophageal cancer.
Indexed in leading databases, the Chinese Journal of Cancer aims to inform researchers, clinicians, and policymakers. It welcomes submissions that contribute to the global effort to conquer cancer. It encourages authors to submit their work, thereby advancing cancer research and enhancing patient care both in China and around the world.